Eczema Therapeutics Market
- 2026 年市場規模
- USD 21.8 Bn
- 2033 年預估規模
- USD 48.7 Bn
- 年複合成長率 CAGR
- 9.7%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Eczema Therapeutics Market, By Treatment (Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin inhibitors, Antibiotics, Immunomodulators, and Interleukin inhibitors), By Distribution Channel (Hospital and Clinics, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Eczema, or dermatitis or atopic dermatitis, is a skin disease that results in inflammation of the skin. A person suffering from eczema suffers from rashes, redness of skin, and itchiness. This skin condition is most common in children and is also seen in the adult population. The symptoms of eczema are different from person to person. Dry itchy red skin, skin rashes, bumpy rashes, and blisters are some of the most common symptoms of this skin disease. Diagnosis of eczema is mostly based on physical examination and in few cases, skin biopsy is performed. The eczema therapeutics aims to control symptoms by reducing inflammation and relieve skin itchiness.
Market Dynamics
Market players are indulged in research and development activities for the treatment of eczema or atopic dermatitis, this is expected to increase the growth of the global eczema therapeutics market over the forecast period. For instance, the researchers at the Oregon Health & Science University, published their research in the New England Journal of Medicine online edition as well as presented their findings at a presentation at the European Academy of Dermatology and Venereology. Their research shows that drug Dupilumab, indicated for atopic dermatitis or eczema, alleviated the skin lesions and intense itching that were previously untreatable by standard medications and often impacted large areas of a trial participant’s body. In turn, the drug also reduced sleep deprivation, depression, and anxiety in participants who suffered from these symptoms because of the severity of eczema.
Increasing awareness for the treatment as well as management of eczema is expected to increase the growth of the global eczema therapeutics market over the forecast period. There are many organizations that are dealing with eczema. They are National Eczema Foundation, National Eczema Society, National Organization of Rare Diseases, International Eczema Council, and Eczema Foundation. Moreover, the Eczema Foundation is under partnership with other institutions and organizations, in order to increase knowledge as well as availability of the treatment options for the eczema, such as Association of the people affected with Atopic Dermatitis, Imperial College London, Eczema Outreach Support, French Association for the prevention of Allergies, and International Society of Atopic Dermatitis etc.
Key features of the study
• This report provides an in-depth analysis of global eczema therapeutics market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global eczema therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Sanofi S.A., Encore Dermatology Inc., AbbieVie Inc., F. Hoffmann-La Roche AG, Novartis AG, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Anacor Pharmaceuticals Inc., Meda AB, GlaxoSmithKline plc, AstraZeneca plc, and Pfizer Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global eczema therapeutics market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the eczema therapeutics market
Market Segmentation
• By Treatment (Revenue, USD Bn, 2021-2033)
o Corticosteroids
o Emollients/Moisturizers
o Antihistamines
o Calcineurin inhibitors
o Antibiotics
o Immunomodulators
o Interleukin inhibitors
• By Distribution Channel (Revenue, USD Bn, 2021-2033)
o Hospital and Clinics
o Retail Pharmacies
o Online Pharmacies
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Sanofi S.A.
o Encore Dermatology Inc
o AbbieVie Inc.
o Hoffmann-La Roche AG
o Novartis AG
o Regeneron Pharmaceuticals Inc.
o Astellas Pharma Inc.
o Anacor Pharmaceuticals Inc.
o Meda AB
o GlaxoSmithKline plc
o AstraZeneca plc
o Pfizer Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Treatment
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Regulatory Scenario
o PEST Analysis
o Recent Product Launch/Approval
o Epidemiology
o Mergers and Acquisitions
4. Global Eczema Therapeutics Market, By Treatment, 2021-2033 (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Corticosteroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Emollients/Moisturizers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Antihistamines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Calcineurin inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Antibiotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Immunomodulators
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Interleukin inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Eczema Therapeutics Market, By Distribution Channel, 2021-2033 (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Eczema Therapeutics Market, By Region, 2021-2033 (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022-2033
Regional Trends
o North America
Market Size and Forecast, By Treatment, 2021-2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Treatment, 2021-2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Treatment, 2021-2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Treatment, 2021-2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Treatment, 2021-2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Treatment, 2021-2033 (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o South Africa
o Central Africa
o North Africa
7. Competitive Landscape
o Company Profiles
Sanofi S.A.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Encore Dermatology Inc
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
AbbieVie Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Hoffmann-La Roche AG
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Novartis AG
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Regeneron Pharmaceuticals Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Astellas Pharma Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Anacor Pharmaceuticals Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Meda AB
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
GlaxoSmithKline plc
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
AstraZeneca plc,
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Pfizer Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
o Analyst Views
8. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們